Clinical trial NCT06445634: Outcome of GATT Combined With Goniosynechiolysis in Glaucoma Patients With Secondary Synechial Angle Closure.
Official title: Outcome of Gonioscopy-Assisted Transluminal Trabeculotomy Combined With Goniosynechiolysis in Glaucoma Patients With Secondary Synechial Angle Closure: A Prospective Case Series
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Glaucoma, Angle-Closure
Keywords: secodary angle closure
GATT
intra ocular pressure
Lead sponsor: Kasr El Aini Hospital
Sponsor class: OTHER
First posted: 2024-06-06
Enrollment: 23
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: prospective cohort
Primary purpose: TREATMENT

Brief summary: To evaluate the intraocular pressure reduction effect of combined gonioscopy-assisted transluminal trabeculotomy (GATT) with goniosynechialysis in eyes with secondary synechial angle closure glaucoma.

Detailed description: Glaucoma is a group of diseases that present with cupping of the optic nerve head and visual-field defects. It is the most common cause of irreversible blindness all over the world.Angle-closure glaucoma is a type of glaucoma characterized by narrowing or closure of the anterior chamber angle.

Two major types of angle closure glaucoma are defined by the mechanism of angle closure: in appositional contact, the iris is pushed by a pressure difference between the posterior and anterior chambers due to relative pupillary block, while in synechial contact, the peripheral iris adheres to the trabecular meshwork by peripheral anterior synechiae (PAS). PAS can develop in various ocular conditions, including: ocular inflammation, a post-traumatic condition, after cataract surgery, or with an iris bombe in a pupillary block glaucoma.

Grover et al. described a technique for ab-Interno circumferential trabeculotomy termed gonioscopy-assisted transluminal trabeculotomy (GATT). The procedure aims to create a 360° trabeculotomy from an ab-Interno approach.

GATT procedure is a MIGS technique in which trabecular meshwork is circumferentially bypassed by incising it using a suture or microcatheter.In this technique, aqueous humor passes through the collector channels and episcleral veins through the cleaved open diseased trabecular meshwork.

Elsayed et al previously demonstrated that combining phacoemulsification with GATT in PACG yielded more favorable outcomes in terms of IOP, glaucoma medications and surgical success compared to phacoemulsification alone.However, to date, no studies have looked at the outcomes of combining goniosynechialysis with GATT in secondary angle closure glaucoma. In fact, most studies looking at the outcomes of GATT in different types of glaucoma excluded eyes with synechial angle closure.

Goniosynechialysis (GSL) is the process of physically separating PAS, which can develop in the trabecular meshwork due to various conditions including primary and secondary cases of angle closure.

So, for those cases of synechial angle closure glaucoma combining GATT and GSL might aid in the IOP lowering effect required.

Eligibility criteria: Inclusion Criteria:

* Patients with secondary synechial angle closure glaucoma
* Involving more than 180 degrees of the iridocorneal angle
* Requiring surgery for uncontrolled IOP despite maximum tolerated therapy.

Exclusion Criteria:

* Eyes with PACG.
* Eyes with neovascular glaucoma. (Some apparently stable NVG cases would have remnants of neo-vessels in the angle that are hidden behind the synechiae).
* Eyes with retinal pathology.
* Eyes requiring combined phacoemulsification and GATT.
* Eyes with corneal pathology that can preclude surgery and imaging.

Primary outcomes:
measure: IOP and glaucoma medications.
timeFrame: 1day,1 week,1 months, 3 months, 6 months and 1 year
measure: Surgical success.
timeFrame: 1day,1 week,1 months, 3 months, 6 months and 1 year
Secondary outcomes:
measure: Complications.
timeFrame: 1day,1 week,1 months, 3 months, 6 months and 1 year
Other outcomes:
Locations:
city: Giza
country: Egypt
facility: Kasralainy Hospitals
Study officials:
References: